Research progress on the influencing factors and intervention measures of opioid requirements

doi:10.19803/j.1672-8629.20240145

Abstract

Abstract: Objective To summarize the existing literature on the influencing factors of opioid drugs, as well as the intervention measures for increasing the supply of legitimate opioid drugs in recent years. Methods The research progress on the influencing factors and intervention measures of opioid drug demand were analyzed by retrieving and screening data from PubMed, CNKI, Wan Fang, and relevant documents, Existing research experience and shortcomings are summarised. Results The influencing factors of clinical measures, patients, and society were summarized at three levels, but currently, relevant research only focuses on one possible influencing factor and lacks exploration of inconsistent results, correlation research, detailed research, and potential factor research; Summarize the intervention measures at each stage of the opioid drug supply process, but there is still a lack of specific research on a specific intervention measure. Conclusion In the future, research on the influencing factors of opioid drug demand can further explore the reasons for inconsistent results, from the perspectives of multi factor joint analysis, refining the measurement dimensions of factors, and exploring new influences; In terms of intervention measures, attention can be paid to the evaluation of their effectiveness and the study of their applicability.

Key words: opioids, requirements, influencing factors, intervention measures, pain management

CLC Number:

R971
R954

QIU Jinghui, ZHOU Huziwei, CAO Ying, LI Wenpeng, WANG Shengfeng. Research progress on the influencing factors and intervention measures of opioid requirements[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 524-528.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20240145

https://www.zgywjj.com/EN/Y2024/V21/I5/524

References

[1] LAN QZ, FANG F, CANG J.Application and new advance of opioids[J]. Chinese Journal of Clinical Medicine(中国临床医学), 2023, 30(4): 736-742.
[2] ROQUES C, MORRISS W, HAYLOCK-LOOR C.The other opioid crisis: the situation in low-resourcecountries[J]. Can J Anaesth, 2022, 69(8): 923-929.
[3] FU VX, OOMENS P, KLIMEK M, et al.The effect of perioperative music on medication requirement and hospital length of stay: a meta-analysis[J]. Ann Surg, 2020, 272(6): 961-972.
[4] HUNG SC, HSU WT, FU CL, et al.Does surgical plethysmographic index-guided analgesia affect opioid requirement and extubation time? A systematic review and meta-analysis[J]. J Anesth, 2022, 36(5): 612-622.
[5] LÓPEZ-RUIZ C, ORJUELA JC, ROJAS-GUALDRÓN DF, et al. Efficacy of transversus abdominis plane block in the reduction of pain and opioid requirement in laparoscopic and robot-assisted hysterectomy: a systematic review and meta-analysis[J]. Rev Bras Ginecol Obstet, 2022, 44(1): 55-66.
[6] KEMPENEERS MA, SCHOLTEN L, VERKADE CR, et al.Efficacy of total pancreatectomy with islet autotransplantation on opioid and insulin requirement in painful chronic pancreatitis: a systematic review and meta-analysis[J]. Surgery, 2019, 166(3): 263-270.
[7] WEN H, XIANG X, JIANG Y, et al.Comparative efficacy of psychosocial interventions for opioid-dependent people receiving methadone maintenance treatment: a network meta-analysis[J]. Addiction, 2023, 118(6): 1029-1039.
[8] RICE D, CORACE K, WOLFE D, et al.Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: a systematic review with network meta-analyses[J]. PLoS One, 2020, 15(12): e0244401.
[9] BOUCK Z, SCHEIM A I, GOMES T, et al.Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions[J]. Int J Drug Policy, 2022, 104: 103680.
[10] CARNES KM, SINGH Z, ATA A, et al.Interventions to reduce opioid prescriptions following urological surgery: a systematic review and meta-analysis[J]. J Urol, 2022, 207(5): 969-981.
[11] CONWAY A, VALERIO H, PEACOCK A, et al.Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: the ETHOS Engage study[J]. Int J Drug Policy, 2021, 96: 103421.
[12] INCB. Supplement to the annual report of the board for2022 on the availability of internationally controlled substances: no patient left behind: progress in ensuring adequate access to internationally controlled substances for medical and scientific purposes [EB/OL]. (2022-03-09)[2024-04-14]. https://www.incb.org/documents/Publications/AnnualReports/AR2022/Supplement/E_INCB_2022_1_Supp_1_eng.pdf.
[13] BOSNJAK SM, MAURER MA, RYAN KM, et al.A multifaceted approach to improve the availability and accessibility of opioids for the treatment of cancer pain in Serbia: results from the international pain policy fellowship (2006-2012) and recommendations for action[J]. J Pain Symptom Manage, 2016, 52(2): 272-283.
[14] UNODC. Technical Guidance: Increasing access and availability of controlled medicines [EB/OL].[2024-04-14]. https://www.unodc.org/unodc/drug-prevention-and-treatment/publications/data/2018/march/technical-guidance_-increasing-access-and-availability-of-controlled-medicines.html.
[15] KRAKAUER EL, NGUYEN TP, HUSAIN SA, et al.Toward safe accessibility of opioid pain medicines in Vietnam and other developing countries: a balanced policy method[J]. J Pain Symptom Manage, 2015, 49(5): 916-922.
[16] FRASER BA, POWELL RA, MWANGI-POWELL FN, et al.Palliative care development in Africa: lessons from Uganda and Kenya[J]. J Glob Oncol, 2018, 4: 1-10.
[17] INCB. Report of the International Narcotics Control Board for2023[EB/OL].[2024-04-14]. https://www.incb.org/documents/Publications/AnnualReports/AR2023/Annual_Report/E_INCB_2023_1_eng.pdf.
[18] TEDESCO D, GORI D, DESAI KR, et al.Drug-free interventions to reduce pain or opioid consumption after total knee arthroplasty: a systematic review and Meta-analysis[J]. JAMA Surg, 2017, 152(10): e172872.
[19] KUTLU YALCIN E, ARAUJO-DURAN J, TURAN A.Emerging drugs for the treatment of postsurgical pain[J]. Expert Opin Emerg Drugs, 2021, 26(4): 371-384.
[20] GOODMAN-MEZA D, FRIEDMAN J, KALMIN MM, et al.Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance data[J]. Lancet Public Health, 2021, 6(2): e88-e96.
[21] SERRA-PUJADAS S, ALONSO-BUXADÉ C, SERRA-COLOMER J, et al.Geographical, socioeconomic, and gender inequalities in opioid use in catalonia[J]. Front Pharmacol, 2021, 12: 750193.
[22] UKERT B, HUANG Y, SENNETT B, et al.State-level variation in opioid prescribing after knee arthroscopy among the opioid-naïve in the USA: 2015-2019[J]. BMJ Open, 2020, 10(8): e035126.
[23] NIKPOUR J, BROOME M, SILVA S, et al.Patient demographics and clinical characteristics influence opioid and nonopioid pain management prescriptions of primary care NPs, PAs, and physicians[J]. J Am Assoc Nurse Pract, 2022, 34(7): 883-890.
[24] LAM L, RICHARDSON MG, ZHAO Z, et al.Enhanced discharge counseling to reduce outpatient opioid use after cesarean delivery: a randomized clinical trial[J]. Am J Obstet Gynecol MFM, 2021, 3(1): 100286.
[25] SCARCELLA MJ, FARROW LD, JONES MH, et al.Opioid use after simple arthroscopic knee surgery[J]. Am J Sports Med, 2022, 50(6): 1644-1650.
[26] TORMOHLEN KN, MOJTABAI R, SEIWELL A, et al.Co-occurring opioid use and depressive disorders: patient characteristics and co-occurring health conditions[J]. J Dual Diagn, 2021, 17(4): 296-303.
[27] CUNNINGHAM DJ, LAROSE MA, KLIFTO CS, et al.Mental health and substance use affect perioperative opioid demand in upper extremity trauma surgery[J]. J Shoulder Elbow Surg, 2021, 30(3): e114-e120.
[28] LIU S, NWABUEZE C, PAN Y, et al.Polysubstance use, mood disorders, and chronic conditions with anxiety in opioid patients[J]. West J Nurs Res, 2022, 44(12): 1088-1099.
[29] HARRIS JD.Editorial commentary: hip preservation and opioids[J]. Arthroscopy, 2020, 36(6): 1608-1611.
[30] YEE L, CAPULE FR, MAKMOR-BAKRY M.Genetic polymorphisms of OPRM1 on the efficacy and safety of anesthetic and analgesic agents: a systematic review[J]. Pharmacogenomics, 2022, 23(10): 609-617.
[31] LI GJ, GUO LW, LIU Y, et al.Research progress on the impact of genetic polymorphism on the perioperative analgesic efficacy of opioid drugs[J]. Journal of Hubei University of Medicine(湖北医药学院学报), 2023, 42(5): 555-560.
[32] PALANISAMI DR, REDDY DA, HUGGI V, et al.Assessing preoperative pain sensitivity predicts the postoperative analgesic requirement and recovery after total knee arthroplasty: a prospective study of 178 patients[J]. J Arthroplasty, 2020, 35(12): 3545-3553.
[33] ANGADI SP, RAMACHANDRAN K, SHETTY AP, et al.Preoperative pain sensitivity predicts postoperative pain severity and analgesics requirement in lumbar fusion surgery-a prospective observational study[J]. Spine J, 2023, 23(9): 1306-1313.
[34] ROBERTSON E, BAMBALA A, KALUNGIA AC, et al.Prescribers' experiences of, and attitudes to, use of morphine for palliative care at a tertiary hospital in Zambia[J]. Hosp Pract, 2020, 48(2): 86-91.
[35] IM EO, LEE SH, LIU Y, et al.A national online forum on ethnic differences in cancer pain experience[J]. Nurs Res, 2009, 58(2): 86-94.
[36] EDRINGTON J, SUN A, WONG C, et al.Barriers to pain management in a community sample of Chinese American patients with cancer[J]. J Pain Symptom Manage, 2009, 37(4): 665-675.
[37] TSAO L, SLATER SE, DOYLE KP, et al. Palliative care-related knowledge, attitudes,self-assessment among physicians in vietnam[J]. J Pain Symptom Manage, 2019, 58(6): 1015-1022.e10.
[38] LARUE F, COLLEAU SM, FONTAINE A, et al.Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France[J]. Cancer, 1995, 76(11): 2375-2382.
[39] YAO J, NGO NV, KIBU OD, et al.Availability and use of essential opioid analgesics in sub-saharan africa: a scoping review protocol[J]. Int J Surg Protoc, 2023, 27(1): 1-8.
[40] SEYA MJ, GELDERS SF, ACHARA OU, et al.A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels[J]. J Pain Palliat Care Pharmacother, 2011, 25(1): 6-18.
[41] QU Z, LIU ZM.Comparison of consumption and demand for opioid analgesics at the national, regional, and global levels by the World Health Organization[J]. Chinese Journal of Drug Dependence(中国药物依赖性杂志), 2012, 21(2): 152-158.
[42] XIE JX, DENG YP, SHI LW.The opioids crisis in the u.s. and the utilization and supervision of analgesics in China[J]. Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志) , 2020, 26(4): 192-197.
[43] ZHANG L, HUANG XX, LIU KK, et al.Overview of management and control of opioids in China[J]. Anti-Tumor Pharmacy(肿瘤药学), 2023, 13(1): 17-22.